切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (05) : 687 -692. doi: 10.3877/cma.j.issn.2095-3232.2025.05.005

专家论坛

门静脉高压症肝脏血供改变对肝移植的影响与对策
王孟龙()   
  1. 100069 首都医科大学附属北京佑安医院普通外科中心暨器官移植科
  • 收稿日期:2025-04-25 出版日期:2025-10-10
  • 通信作者: 王孟龙

Impact of changes in hepatic blood flow in portal hypertension on liver transplantation and corresponding countermeasures

Menglong Wang()   

  1. General Surgery Center & Department of Organ Transplantation, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China
  • Received:2025-04-25 Published:2025-10-10
  • Corresponding author: Menglong Wang
引用本文:

王孟龙. 门静脉高压症肝脏血供改变对肝移植的影响与对策[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 687-692.

Menglong Wang. Impact of changes in hepatic blood flow in portal hypertension on liver transplantation and corresponding countermeasures[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(05): 687-692.

肝移植(LT)是门静脉高压症(PHT)的最终治疗手段。PHT时门静脉血栓(PVT)形成、门静脉海绵样变(CTPV)、脾动脉窃血综合征(SASS)等病理生理改变对移植肝血供有重要影响,不仅大大增加LT手术风险,还有可能影响移植肝的长期生存。术前要合理选择适应证,最好预备多种血管重建方案。术中取栓和寻找可利用的内脏静脉是关键,尽可能控制创伤面和缩短手术时间是减少围手术期并发症和死亡的最重要的明智之举。而对门静脉和肝动脉灌注的监测应贯穿LT前后全过程。本文就PHT时门静脉与肝动脉的常见病理改变、形成机制、对LT术中术后近远期影响及对策,进行梳理与探讨。

Liver transplantation (LT) is the ultimate treatment for portal hypertension (PHT). Pathophysiological changes such as portal vein thrombosis (PVT), cavernous transformation of portal vein (CTPV) and splenic artery steal syndrome (SASS) during PHT exert significant impact on the blood supply of liver allograft, which not only significantly increases the risk of LT, but also probably affects the long-term survival of liver allograft. Preoperatively, surgical indications should be selected reasonably, and it is recommended to prepare multiple regimens for vascular reconstruction. Intraoperative embolectomy and identifying usable veins are key procedures. Controlling wound surface and shortening the operation time play crucial roles in reducing perioperative complications and death. The monitoring of portal vein and hepatic artery perfusion should be performed throughout the whole process before and after LT. In this article, common pathological changes of portal vein and hepatic artery during PHT, underlying mechanism, short-term and long-term effects on intraoperative and postoperative periods of LT and corresponding countermeasures were illustrated and discussed.

图1 PHT的成因及其病理生理机制示意图 注:门静脉回流受阻或血流量增加或两者兼而有之,可引起PHT。代偿性门体侧支循环形成和内脏小动脉舒张导致血液潴滞于内脏并分流到体循环,相应减少肝动脉和门静脉供血,即“内脏窃血”,脾动脉窃血为其中一部分,PHT为门静脉高压症
图2 PHT患者肝移植术中门静脉重建方式示意图 注:a为门静脉-门静脉端端吻合,首选方案,必要时结扎粗大的分流支;b为门静脉-内脏静脉吻合或搭桥,脾静脉、肠系膜上静脉、胃冠状静脉或者海绵样曲张血管粗大分支均可作为备选;c为门静脉-非内脏静脉重建,肝动脉、左肾静脉或肝下下腔静脉均可用于抢救性重建,如果存在粗大的脾肾分流支,可行门静脉-左肾静脉端端血管搭桥,相当于生理性吻合;PHT为门静脉高压症
[1]
Klupp J, Kohler S, Pascher A, et al. Liver transplantation as ultimate tool to treat portal hypertension[J]. Dig Dis, 2005, 23(1): 65-71. DOI: 10.1159/000084727.
[2]
Bhangui P, Fernandes ESM, Di Benedetto F, et al. Current management of portal vein thrombosis in liver transplantation[J]. Int J Surg, 2020, 82S: 122-127. DOI: 10.1016/j.ijsu.2020.04.068.
[3]
Mao W, Jiang X, Guo S, et al. Splenic artery steal syndrome in patients with liver cirrhosis: a retrospective clinical study[J]. Med Sci Monit, 2023, 29: e938998. DOI: 10.12659/MSM.938998.
[4]
Usai S, Colasanti M, Meniconi RL, et al. Splenic artery steal syndrome after liver transplantation-prophylaxis or treatment? A case report and literature review[J]. Ann Hepatobiliary Pancreat Surg, 2022, 26(4): 386-394. DOI: 10.14701/ahbps.22-004.
[5]
Saad WEA. Nonocclusive hepatic artery hypoperfusion syndrome (splenic steal syndrome) in liver transplant recipients[J]. Semin Intervent Radiol, 2012, 29(2): 140-146. DOI: 10.1055/s-0032-1312576.
[6]
Pinto S, Reddy SN, Horrow MM, et al. Splenic artery syndrome after orthotopic liver transplantation: a review[J]. Int J Surg, 2014, 12(11): 1228-1234. DOI: 10.1016/j.ijsu.2014.09.012.
[7]
Abdel-Misih SR, Bloomston M. Liver anatomy[J]. Surg Clin North Am, 2010, 90(4): 643-653. DOI: 10.1016/j.suc.2010.04.017.
[8]
Buob S, Johnston AN, Webster CL. Portal hypertension: pathophysiology, diagnosis, and treatment[J]. J Vet Intern Med, 2011, 25(2): 169-186. DOI: 10.1111/j.1939-1676.2011.00691.x.
[9]
Iwakiri Y. Pathophysiology of portal hypertension[J]. Clin Liver Dis, 2014, 18(2): 281-291. DOI: 10.1016/j.cld.2013.12.001.
[10]
Gunarathne LS, Rajapaksha H, Shackel N, et al. Cirrhotic portal hypertension: from pathophysiology to novel therapeutics[J]. World J Gastroenterol, 2020, 26(40): 6111-6140. DOI: 10.3748/wjg.v26.i40.6111.
[11]
Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but ‘splanchnic steal’[J]. QJM, 2002, 95(12): 827-830. DOI: 10.1093/qjmed/95.12.827.
[12]
Hepatobiliary Disease Study Group CSOG. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)[J]. J Dig Dis, 2021, 22(4): 176-186. DOI: 10.1111/1751-2980.12970.
[13]
Wei B, Huang Z, Tang C. Optimal treatment for patients with cavernous transformation of the portal vein[J]. Front Med, 2022, 9: 853138. DOI: 10.3389/fmed.2022.853138.
[14]
De Gaetano AM, Lafortune M, Patriquin H, et al. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography[J]. AJR Am J Roentgenol, 1995, 165(5): 1151-1155. DOI: 10.2214/ajr.165.5.7572494.
[15]
Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation[J]. J Hepatol, 2012, 57(1): 203-212. DOI: 10.1016/j.jhep.2011.12.034.
[16]
Zanetto A, Rodriguez-Kastro KI, Germani G, et al. Mortality in liver transplant recipients with portal vein thrombosis: an updated meta-analysis[J]. Transpl Int, 2018, 31(12): 1318-1329. DOI: 10.1111/tri.13353.
[17]
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69(9): 1873-1881. DOI: 10.1097/00007890-200005150-00023.
[18]
Jamieson NV. Changing perspectives in portal vein thrombosis and liver transplantation[J]. Transplantation, 2000, 69(9): 1772-1774. DOI: 10.1097/00007890-200005150-00006.
[19]
Charco R, Fuster J, Fondevila C, et al. Portal vein thrombosis in liver transplantation[J]. Transplant Proc, 2005, 37(9): 3904-3905. DOI: 10.1016/j.transproceed.2005.09.120.
[20]
Bhangui P, Lim C, Levesque E, et al. Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation[J]. J Hepatol, 2019, 71(5): 1038-1050. DOI: 10.1016/j.jhep.2019.08.012.
[21]
Rajesh S, Philips CA, Ahamed R, et al. Friend or foe? Spontaneous portosystemic shunts in cirrhosis-current understanding and future prospects[J]. Can J Gastroenterol Hepatol, 2021, 2021: 8795115. DOI: 10.1155/2021/8795115.
[22]
Karagiannakis DS. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?[J]. World J Gastroenterol, 2024, 30(20): 2621-2623. DOI: 10.3748/wjg.v30.i20.2621.
[23]
Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases[J]. Ann Surg, 2014, 259(4): 760-766. DOI: 10.1097/SLA.0000000000000252.
[24]
Tekin A, Beduschi T, Vianna R, et al. Multivisceral transplant as an option to transplant cirrhotic patients with severe portal vein thrombosis[J]. Int J Surg, 2020, 82: 115-121. DOI: 10.1016/j.ijsu.2020.07.010.
[25]
Sampaio RL, Coelho GR, Mesquita DFG, et al. Left gastric vein direct anastomosis as alternative to portal flow reconstruction in liver transplantation[J]. Ann Surg Open, 2024, 5(1): e382. DOI: 10.1097/AS9.0000000000000382.
[26]
D’Amico G, Hassan A, Diago Uso T, et al. Renoportal anastomosis in liver transplantation and its impact on patient outcomes: a systematic literature review[J]. Transpl Int, 2019, 32(2): 117-127. DOI: 10.1111/tri.13368.
[27]
Kato T, Levi DM, DeFaria W, et al. Liver transplantation with renoportal anastomosis after distal splenorenal shunt[J]. Arch Surg, 2000, 135(12): 1401-1404. DOI: 10.1001/archsurg.135.12.1401.
[28]
Pinelli D, Neri F, Tornese S, et al. Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis[J]. Updates Surg, 2022, 74(5): 1617-1626. DOI: 10.1007/s13304-022-01280-y.
[29]
D’Amico G, Matsushima H, Del Prete L, et al. Long term outcomes and complications of reno-portal anastomosis in liver transplantation: results from a propensity score-based outcome analysis[J]. Transpl Int, 2021, 34(10): 1938-1947. DOI: 10.1111/tri.13920.
[30]
Li C, Kapoor B, Moon E, et al. Current understanding and management of splenic steal syndrome after liver transplant: a systematic review[J]. Transplant Rev, 2017, 31(3): 188-192. DOI: 10.1016/j.trre.2017.02.002.
[31]
Durur Karakaya A, Çil BE, Kanmaz T, et al. Non-occlusive hepatic artery hypoperfusion syndrome and imaging findings: a systematic review[J]. Abdom Radiol, 2021, 46(6): 2467-2473. DOI: 10.1007/s00261-020-02850-7.
[32]
Saad Eddin A, Kamaraju A, Ramzan U, et al. Splenic artery steal syndrome after liver transplantation: a case series and review of literature[J]. Clin Case Rep, 2024, 12(5): e8930. DOI: 10.1002/ccr3.8930.
[1] 孙丕绛, 崔上, 杨永君, 冉超, 王槐志. 腹腔镜下肠系膜上动脉优先入路联合门静脉切除重建扩大清扫胰十二指肠切除术(en-bolc)[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 487-487.
[2] 周家康, 刘忠忠, 张涛, 叶少军, 熊艳. 肝移植术后抗体介导排斥反应合并肺孢子菌肺炎一例[J/OL]. 中华移植杂志(电子版), 2025, 19(03): 193-196.
[3] 孙爽, 赵凯, 王淑贤, 徐祥美, 戴德淑, 张良灏, 付子萱, 蔡金贞, 许传屾. 肝移植围手术期应激性心肌病一例[J/OL]. 中华移植杂志(电子版), 2025, 19(03): 197-200.
[4] 关雪, 于颖, 李京, 刘莹, 崔亚娟, 刘名鹤. 肝移植受者术后下肢深静脉血栓形成风险预测模型的建立[J/OL]. 中华移植杂志(电子版), 2025, 19(03): 138-144.
[5] 中华医学会器官移植学分会肝移植学组, 中国医师协会器官移植医师分会. 中国扩大标准供肝移植临床应用指南(2025版)[J/OL]. 中华移植杂志(电子版), 2025, 19(02): 65-75.
[6] 中华医学会器官移植学分会肝移植学组, 中国医师协会器官移植医师分会. 中国自身免疫性肝病肝移植受者免疫抑制方案应用指南[J/OL]. 中华移植杂志(电子版), 2025, 19(02): 76-85.
[7] 杨烨, 王兢. 肝移植手术室标准化操作流程在临床实践中的效果评价[J/OL]. 中华移植杂志(电子版), 2025, 19(02): 110-113.
[8] 杨汉文, 徐诗扬, 王强, 张朋朋, 成柯, 赵于军. 混合型肝硬化合并经颈静脉肝内门体分流术后肝性脊髓病行肝移植一例[J/OL]. 中华移植杂志(电子版), 2025, 19(02): 117-119.
[9] 刘亦婷, 申英末. 腹腔镜修补手术在肝移植术后切口疝的应用及其效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(02): 202-205.
[10] 鲁旭, 李华. 结直肠癌肝转移肝移植治疗研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 508-514.
[11] 张宏伟, 邢玉雪, 贾哲, 赫嵘, 张珂, 蒋力. 术前输注血小板在肝癌合并肝硬化门静脉高压症肝脾联合切除患者中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 576-581.
[12] 阿里木江·马木提, 吐尔洪江·吐逊. 肝泡型棘球蚴病外科治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 475-480.
[13] 石洋, 郭辉, 李坚. 门静脉高压症TIPS操作规范及其手术相关并发症处理[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 372-378.
[14] 徐涵治, 邱洵, 汪恺, 徐骁. 脂肪变性供肝脱脂策略的研究[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 18-24.
[15] 伊力扎提·阿扎提, 吐尔洪江·吐逊. 腹腔镜活体供肝切取术的临床现状[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 30-35.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?